Choose a language and wait for the translated text.
The Central Drugs Standard Control Organisation and the office of Drugs Controller Assam ordered the shutdown on August 20 after a joint federal-state inspection of the facility identified lapses in the system meant to ensure product quality and safety, following Sun Pharma's move in July to voluntarily recall about 11 eye-care brands.
Sun Pharma ordered to halt eye drug production at Assam plant over quality lapses | PharmaVoice
